Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs497908 | chr13:37512624 | G/A | 0.00037 | 177 | 6.37 | 24.47 | 25.7 | KM Plot |
PCPG | rs4992515 | chr16:8763235 | A/C | 0 | 178 | 25.47 | 23.53 | 3.17 | KM Plot |
PCPG | rs5011845 | chr8:11305322 | C/T | 8.04E-6 | 178 | 25.53 | 22.63 | 14.15 | KM Plot |
PCPG | rs5020720 | chr5:13803158 | A/C | 0.000478 | 178 | 28.47 | 18.7 | 24.33 | KM Plot |
PCPG | rs5025124 | chr8:135494243 | C/T | 0.000457 | 178 | 25.4 | 24.7 | 28.95 | KM Plot |
PCPG | rs523628 | chr3:53505928 | G/A | 0.00026 | 170 | 31.43 | 22.35 | 25.6 | KM Plot |
PCPG | rs534622 | chr3:80681027 | C/T | 0.000182 | 176 | 19.53 | 24.5 | 27.2 | KM Plot |
PCPG | rs551315 | chr3:80683010 | A/G | 0.000181 | 176 | 19.53 | 24.5 | 27.2 | KM Plot |
PCPG | rs55649270 | chr20:10637337 | T/G | 0.000181 | 175 | 24.52 | 29.43 | 14.28 | KM Plot |
PCPG | rs55650580 | chr2:241526259 | T/A | 3.68E-5 | 177 | 25.97 | 20.2 | 10.3 | KM Plot |
PCPG | rs55653896 | chr16:89578057 | C/T | 0.000325 | 174 | 26.78 | 25.4 | 19.87 | KM Plot |
PCPG | rs55670239 | chr13:54165284 | G/T | 0.000228 | 177 | 25.77 | 20.17 | 3.17 | KM Plot |
PCPG | rs55671732 | chr16:85227077 | G/GT | 1.76E-7 | 171 | 25.92 | 23.43 | 17.43 | KM Plot |
PCPG | rs55683052 | chr17:80527445 | T/C | 8.78E-7 | 175 | 25.53 | 24.53 | 8.75 | KM Plot |
PCPG | rs55691539 | chr7:105165774 | T/C | 5.73E-5 | 176 | 20.17 | 30.45 | 2.28 | KM Plot |